Compound Summary
药名: | Cholanoic acid |
别名: | 5.beta.-Cholanic acid; CHEBI:36238; Cholan-24-oic acid, (5beta)- (9CI); LMST04010441; Cholan-24-oic acid, (5.beta.)-; (4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid; NSC18161; (4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; Ursocholanic acid; 5beta-Cholanoic acid; 5beta-Cholan-24-oic acid (8CI); NSC 18161; Androstane-17-butanoic acid, gamma-methyl-, (5beta,17beta)-; 5beta-Cholan-24-oic Acid; 5.beta.-Cholan-24-oic acid; L 596205-0; 5beta-Cholanic acid; Androstane-17-butanoic acid, .gamma.-methyl-, (5.beta.,17.beta.)-; (5beta)-cholan-24-oic acid; 546-18-9; 5.beta.-Cholanoic acid; (5beta,17beta)-gamma-methylandrostane-17-butanoic acid |
分子式: | C24H40O2 |
Smiles: | CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCCC4)C)C |
成分: | HBIN020390 |
OB_score: | 18.952216 |
CAS_id: | 546-18-9 |
SymMap_id: | SMIT03866 |
TCMSP_id: | MOL001446 |
PubChem_id: | 92803 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE007950 | Herba Lycopi;Eupatorium compositifolium | 泽兰 | 1. To invigorate blood and remove stagnation; 2. To promote urination and reduce edema/Amenorrhea, concretion and conglomeration, postpartum blood stasis abdominal pain, edema in body and face, knocks and falls, incised wound. | |||
TCMBANKHE006352 | Abrus Precatorius L. | 相思子 | Vomiting, welling abscess, parotitis, scab and lichen, wind-damp bone pain. | |||
TCMBANKHE009016 | Herba Lycopi | 泽兰叶;泽兰 | Treatment of menstrual disorders, amenorrhea, dysmenorrhea, postpatum abdominal pain due to blood stasis, edema.1. To invigorate blood and remove stagnation; 2. To promote urination and reduce edema/Treatment of menstrual disorders, amenorrhea, dysmenorrhea, postpatum abdominal pain due to blood stasis, edema.Amenorrhea, concretion and conglomeration, postpartum blood stasis abdominal pain, edema in body and face, knocks and falls, incised wound. |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000201 | ESR1 | ER; ESR; ESRA; ESTRR; Era; NR3A1 | estrogen receptor 1 |
TCMBANKGE000476 | NCOA2 | GRIP1; KAT13C; NCoA-2; SRC2; TIF2; bHLHe75 | nuclear receptor coactivator 2 |
TCMBANKGE000737 | PGR | NR3C3; PR | progesterone receptor |
TCMBANKGE000766 | ACHE | ACEE; ARACHE; N-ACHE; YT | acetylcholinesterase (Cartwright blood group) |
TCMBANKGE000938 | CDK2 | CDKN2; p33(CDK2) | cyclin dependent kinase 2 |
TCMBANKGE001755 | MAOB | - | monoamine oxidase B |
TCMBANKGE004266 | AR | AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM | androgen receptor |
TCMBANKGE006339 | CA2 | CA-II; CAC; CAII; Car2; HEL-76; HEL-S-282 | carbonic anhydrase 2 |
TCMBANKGE006886 | ADH1A | ADH1 | alcohol dehydrogenase 1A (class I), alpha polypeptide |
TCMBANKGE008718 | PRSS3 | MTG; PRSS4; T9; TRY3; TRY4 | serine protease 3 |
TCMBANKGE009389 | LYZ | LYZF1; LZM | lysozyme |
TCMBANKGE011079 | PRSS1 | TRP1; TRY1; TRY4; TRYP1 | serine protease 1 |
TCMBANKGE011214 | DAO | DAAO; DAMOX; OXDA | D-amino acid oxidase |
TCMBANKGE013105 | PLA2G2E | GIIE sPLA2; sPLA2-IIE | phospholipase A2 group IIE |